or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    MRNA C Moderna, Inc. -5.90
    EVAX D Evaxion Biotech A/S 1.96
    AGEN F Agenus Inc. 3.84
    INDP F Indaptus Therapeutics, Inc. -4.44
    RENB F Renovaro Biosciences Inc. 1.36
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    GERM B ETFMG Treatments Testing and Advancements ETF 10.44
    BBH B Market Vectors Biotech ETF 8.31
    IDNA C iShares Genomics Immunology and Healthcare ETF 6.9
    IBBQ B Invesco Nasdaq Biotechnology ETF 6.64
    GNOM D Global X Genomics & Biotechnology ETF 5.78
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare BBH to IBBQ Compare BBH to IDNA Compare IBBQ to GNOM

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        Jun 1 MRNA Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)
        May 31 MRNA Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
        May 31 MRNA Moderna Gets FDA Approval For Respiratory Syncytial Virus Vaccine for Seniors
        May 31 MRNA Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars
        May 31 MRNA Moderna Looks for Boost From Newly Approved RSV Shot
        May 31 MRNA Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
        May 31 MRNA Moderna wins FDA approval for RSV vaccine
        May 31 MRNA Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
        May 30 MRNA Why Moderna Stock Is Sinking This Week
        May 30 MRNA The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
        May 30 MRNA Third human bird flu case found in U.S.
        May 30 MRNA The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and Qualcomm
        May 30 MRNA Option Trade On Volatile Moderna Could Return 28% By Mid-July
        May 30 MRNA Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT
        May 30 MRNA Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
        May 30 MRNA Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
        May 29 MRNA The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
        May 29 MRNA VIX Rises 8%, Treasury Yields Jump, Dow Plunges: Why Is Wall Street Wobbling Thursday?
        May 29 MRNA Nasdaq Tops 17K: 5 Best-Performing Stocks in ETF YTD
        May 29 MRNA Moderna Stock Is Having Another Very Bad Day. Here’s Why.
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags